Xinyi Guo

4.5k total citations · 2 hit papers
113 papers, 2.6k citations indexed

About

Xinyi Guo is a scholar working on Molecular Biology, Genetics and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Xinyi Guo has authored 113 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 25 papers in Genetics and 22 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Xinyi Guo's work include Genomics and Phylogenetic Studies (33 papers), Plant Ecology and Taxonomy Studies (19 papers) and Genetic diversity and population structure (18 papers). Xinyi Guo is often cited by papers focused on Genomics and Phylogenetic Studies (33 papers), Plant Ecology and Taxonomy Studies (19 papers) and Genetic diversity and population structure (18 papers). Xinyi Guo collaborates with scholars based in China, United States and Czechia. Xinyi Guo's co-authors include Ming-Hui Dong, Zhouzerui Liu, Tiansheng Yan, Liang Jin, Xianwen Ren, Chunhong Zheng, Zemin Zhang, Rui Xing, Ranran Gao and Dennis Kirchhoff and has published in prestigious journals such as Nature Medicine, Nature Communications and Nature Biotechnology.

In The Last Decade

Xinyi Guo

93 papers receiving 2.6k citations

Hit Papers

Global characterization of T cells in non-small-cell lung... 2018 2026 2020 2023 2018 2025 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing
    2018 990 citations Xinyi Guo et al. profile →
  2. Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer
    2025 18 citations Xinyi Guo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinyi Guo China 21 1.2k 676 633 283 278 113 2.6k
Dirk Metzler Germany 28 1.5k 1.2× 693 1.0× 416 0.7× 314 1.1× 410 1.5× 82 3.1k
Hatisaburo Masuda Brazil 33 1.4k 1.1× 392 0.6× 428 0.7× 224 0.8× 117 0.4× 76 3.0k
Pengfei Ma China 33 1.8k 1.5× 387 0.6× 478 0.8× 620 2.2× 408 1.5× 124 3.2k
Wei Dang China 30 2.1k 1.7× 393 0.6× 767 1.2× 148 0.5× 428 1.5× 101 3.9k
Agnes Hotz‐Wagenblatt Germany 34 2.1k 1.7× 319 0.5× 461 0.7× 239 0.8× 673 2.4× 79 3.2k
Matthew J. Brauer United States 17 2.4k 2.0× 376 0.6× 635 1.0× 221 0.8× 221 0.8× 24 4.1k
Takeshi Suzuki Japan 36 2.1k 1.8× 295 0.4× 688 1.1× 375 1.3× 176 0.6× 112 4.0k
Urban Gullberg Sweden 35 1.6k 1.3× 554 0.8× 1.2k 1.8× 710 2.5× 396 1.4× 132 4.0k
Vladimir Vincek United States 34 953 0.8× 386 0.6× 1.6k 2.5× 141 0.5× 156 0.6× 132 3.7k
Gregory Hinkle United States 16 1.9k 1.6× 257 0.4× 199 0.3× 231 0.8× 257 0.9× 20 2.7k

Countries citing papers authored by Xinyi Guo

Since Specialization
Citations

This map shows the geographic impact of Xinyi Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyi Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyi Guo more than expected).

Fields of papers citing papers by Xinyi Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyi Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyi Guo. The network helps show where Xinyi Guo may publish in the future.

Co-authorship network of co-authors of Xinyi Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyi Guo. A scholar is included among the top collaborators of Xinyi Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyi Guo. Xinyi Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Lu, Silin Chen, Xinyi Guo, et al.. (2025). Recent advancements in the design and application of Thioctic acid-based self-assembled materials. Coordination Chemistry Reviews. 537. 216679–216679. 3 indexed citations
2.
Guo, Xinyi, et al.. (2025). Phosphorothiolation of Benzylic C(sp 3 )–H via EnT-Mediated Radical–Radical Cross-Coupling. Organic Letters. 28(1). 515–521.
3.
Yang, Guo‐Sheng, Meng Zhang, Peng Guo, et al.. (2025). High-Precision Error Bit Prediction for 3D QLC NAND Flash Memory: Observations, Analysis, and Modeling. IEEE Transactions on Computers. 74(4). 1392–1404. 1 indexed citations
4.
Zhang, Meng, Xuepeng Zhan, Peng Guo, et al.. (2025). Retention Accelerated Testing for 3-D QLC nand Flash Memory: Characterization, Analysis, and Modeling. IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems. 44(7). 2779–2788. 1 indexed citations
5.
6.
Hu, Menglu, Bo Zhang, Yuanyue Shan, et al.. (2025). Scalable modulation of CRISPR‒Cas enzyme activity using photocleavable phosphorothioate DNA. Nature Communications. 16(1). 5939–5939. 3 indexed citations
7.
8.
9.
Zhao, Linghao, Xinyi Guo, Jian‐Shuang Jiang, et al.. (2024). A class of geranylquinol-derived polycyclic meroterpenoids from Arnebia euchroma against heart failure by reducing excessive autophagy and apoptosis in cardiomyocytes. Bioorganic Chemistry. 151. 107691–107691. 2 indexed citations
10.
Dolman, M. Emmy M., Dannielle Upton, Jie Liu, et al.. (2024). DIPG-50. TARGETING VULNERABILITIES IN PAEDIATRIC DIFFUSE MIDLINE GLIOMAS: LEVERAGING PLK1 INHIBITION TO EXPLOIT RAS/PI3K PATHWAY DEPENDENCY. Neuro-Oncology. 26(Supplement_4). 0–0.
11.
Shan, Yuanyue, Mengmeng Zhang, Mei‐Yu Chen, et al.. (2024). Activation mechanisms of dimeric mechanosensitive OSCA/TMEM63 channels. Nature Communications. 15(1). 7504–7504. 8 indexed citations
12.
Shan, Yuanyue, et al.. (2024). Structure of human PIEZO1 and its slow-inactivating channelopathy mutants. eLife. 13. 4 indexed citations
13.
Wang, Chao, Yan Cheng, Hongli Wang, et al.. (2024). Discovery of Novel ERα and Aromatase Dual-Targeting PROTAC Degraders to Overcome Endocrine-Resistant Breast Cancer. Journal of Medicinal Chemistry. 67(11). 8913–8931. 18 indexed citations
14.
Liu, Changxing, Xinyi Guo, & Xulong Zhang. (2024). Modulation of atherosclerosis‐related signaling pathways by Chinese herbal extracts: Recent evidence and perspectives. Phytotherapy Research. 38(6). 2892–2930. 9 indexed citations
15.
Guo, Xinyi, et al.. (2024). METTL14/miR‐29c‐3p axis drives aerobic glycolysis to promote triple‐negative breast cancer progression though TRIM9‐mediated PKM2 ubiquitination. Journal of Cellular and Molecular Medicine. 28(3). e18112–e18112. 13 indexed citations
16.
Liu, Changxing, Xinyi Guo, Yabin Zhou, & He Wang. (2024). Therapeutic Role of Chinese Medicine Targeting Nrf2/HO-1 Signaling Pathway in Myocardial Ischemia/Reperfusion Injury. Chinese Journal of Integrative Medicine. 30(10). 949–960. 2 indexed citations
17.
18.
19.
Liscovitch‐Brauer, Noa, Antonino Montalbano, Alejandro Méndez‐Mancilla, et al.. (2021). Profiling the genetic determinants of chromatin accessibility with scalable single-cell CRISPR screens. Nature Biotechnology. 39(10). 1270–1277. 64 indexed citations
20.
Yang, Xiaoyue, Zefu Wang, Wenchun Luo, et al.. (2019). Plastomes of Betulaceae and phylogenetic implications. Journal of Systematics and Evolution. 57(5). 508–518. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dirk Metzler Breakdown of academic impact, for papers by Hatisaburo Masuda Breakdown of academic impact, for papers by Pengfei Ma Breakdown of academic impact, for papers by Wei Dang Breakdown of academic impact, for papers by Agnes Hotz‐Wagenblatt Breakdown of academic impact, for papers by Matthew J. Brauer Breakdown of academic impact, for papers by Takeshi Suzuki Breakdown of academic impact, for papers by Urban Gullberg Breakdown of academic impact, for papers by Vladimir Vincek Breakdown of academic impact, for papers by Gregory Hinkle
Rankless by CCL
2026